Table 4 Current medications among hyperthyroid patients attending UoGCSH
Treatment modality | Frequency (%) |
|---|---|
PTU | 211 (100%) |
Propranolol | 94 (44.55%) |
Metoprolol | 3 (1.42%) |
Atenolol | 131 (62.09%) |
Amlodipine | 8 (11.76%) |
Furosemide | 39 (53.33%) |
Spironolactone | 18 (26.46%) |
Captopril | 1 (1.47%) |
Aspirin | 5 (7.35%) |
Enalapril | 8 (11.76%) |
Digoxin | 13 (19.11%) |
Warfarin | 8 (11.76%) |
Salbutamol | 3 (4.41%) |
Antiretroviral therapy | 2 (2.94%) |
Verapamil | 1 (1.47%) |
Hydrochlorothiazide | 9 (13.23%) |